These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2006804)

  • 21. The effect of famotidine on gastroesophageal and duodeno-gastro-esophageal refluxes in critically ill patients.
    Xin Y; Dai N; Zhao L; Wang JG; Si JM
    World J Gastroenterol; 2003 Feb; 9(2):356-8. PubMed ID: 12532466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical aspects of Kvamatel (famotidine) administration].
    Golochevskaia VS
    Klin Med (Mosk); 1996; 74(1):45-7. PubMed ID: 8649009
    [No Abstract]   [Full Text] [Related]  

  • 23. [Gastroesophageal reflux disease in preschool children with asthma].
    Yoshida Y; Kameda M; Nishikido T; Takamatu I; Doi S
    Arerugi; 2008 May; 57(5):529-35. PubMed ID: 18520174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of gastric pH with omeprazole magnesium 20.6 mg (Prilosec OTC) o.m. famotidine 10 mg (Pepcid AC) b.d. and famotidine 20 mg b.d. over 14 days of treatment.
    Miner PB; Allgood LD; Grender JM
    Aliment Pharmacol Ther; 2007 Jan; 25(1):103-9. PubMed ID: 17229225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ultrasonographic evaluation of lansoprazole-induced improvement of submucosal injury in patients with gastroesophageal reflux.
    Mine S; Fujisaki T; Tabata T; Matsuoka H; Iida T; Yamada S; Tanaka Y; Morimoto I; Eto S; Aibe T
    Am J Gastroenterol; 2000 Feb; 95(2):381-6. PubMed ID: 10685739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The clinical use of histamine-2 receptor antagonists.
    Michocki RJ; Richardson JP
    Md Med J; 1992 May; 41(5):397-400. PubMed ID: 1625532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Famotidine 40mg B.I.D. in the treatment of reflux oesophagitis.
    Ahmed W; Qureshi H; Alam SE; Zuberi SJ
    J Pak Med Assoc; 1995 Sep; 45(9):241-3. PubMed ID: 8683830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The effect of cimetidine and famotidine on esophageal motility].
    Paradowski L; Salomon A; Szelag A
    Pol Tyg Lek; 1996 Apr; 51(14-18):227-9. PubMed ID: 8966165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of blockade of histamine H2 receptors on chronic heart failure revealed by retrospective and prospective randomized studies.
    Kim J; Ogai A; Nakatani S; Hashimura K; Kanzaki H; Komamura K; Asakura M; Asanuma H; Kitamura S; Tomoike H; Kitakaze M
    J Am Coll Cardiol; 2006 Oct; 48(7):1378-84. PubMed ID: 17010798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative effectiveness of histamine-2 receptor antagonists as short-term therapy for gastro-esophageal reflux disease: a network meta-analysis.
    Zhao F; Wang S; Liu L; Wang Y
    Int J Clin Pharmacol Ther; 2016 Oct; 54(10):761-70. PubMed ID: 27443665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of a new H2-blocker, famotidine, in reflux esophagitis among severely handicapped children.
    Miyake S; Yamada M; Iwamoto H; Yamashita S; Sugio Y
    Clin Ther; 1987; 9(5):548-58. PubMed ID: 2889529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of gastroesophageal reflux disease.
    Pettit M
    Pharm World Sci; 2005 Dec; 27(6):432-5. PubMed ID: 16341949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.
    Bardhan KD
    Yale J Biol Med; 1996; 69(3):211-24. PubMed ID: 9165690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro effects of famotidine and ranitidine on lower esophageal sphincter tone in rats.
    Özer M; Duman M; Taş Ş; Demırcı Y; Aydin MF; Reyhan E; Atici AE; Bostanci EB; Akoğlu M; Genç E
    Turk J Gastroenterol; 2012; 23(5):438-43. PubMed ID: 23161288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
    Hatlebakk JG; Berstad A
    Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prevention of the recurrence of duodenal ulcer with famotidine. Report of experiences with long-term therapy in an open clinical study].
    Judmaier G
    Wien Med Wochenschr; 1992; 142(18):406-7. PubMed ID: 1475985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adverse effects reported in the use of gastroesophageal reflux disease treatments in children: a 10 years literature review.
    Cohen S; Bueno de Mesquita M; Mimouni FB
    Br J Clin Pharmacol; 2015 Aug; 80(2):200-8. PubMed ID: 25752807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of symptoms in step-down therapy of gastroesophageal reflux disease.
    Mine S; Iida T; Tabata T; Kishikawa H; Tanaka Y
    J Gastroenterol Hepatol; 2005 Sep; 20(9):1365-70. PubMed ID: 16105122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Update on gastroesophageal reflux disease.
    Ledger S
    CANNT J; 2005; 15(4):44-7; quiz 48-9. PubMed ID: 16491998
    [No Abstract]   [Full Text] [Related]  

  • 40. Influence of acid suppressants on gastric emptying: cross-over analysis in healthy volunteers.
    Takahashi Y; Amano Y; Yuki T; Ose T; Miyake T; Kushiyama Y; Sato S; Ishihara S; Kinoshita Y
    J Gastroenterol Hepatol; 2006 Nov; 21(11):1664-8. PubMed ID: 16984586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.